Dr. Eli Gang ranked among America's Best Doctors
August 16, 2011
Magnetecs Corporation, a designer and manufacturer of robotic catheterization control systems for minimally invasive surgical procedures, today reported that Dr. Eli Gang, M.D., Chief Medical Officer of Magnetecs and Clinical Professor of Medicine, Geffen School of Medicine at UCLA, has been ranked among America’s Top Doctors®, according to a peer survey conducted by U.S. News & World Report magazine.
In the recently released survey, Dr. Gang ranked in the top one percent of physicians in the specialty of cardiology and heart surgery. The listing is published annually and compiled from surveys and interviews conducted with hundreds of thousands of physicians and healthcare professionals to identify the top specialists across the country. This peer nomination process is designed to help patients find the best physicians and to increase physician awareness of peers most worthy of referral.
Dr. Eli Gang, Chief Medical Officer of Magnetecs
“I’m honored by this recognition and support for longstanding efforts to give patients the best care I am able to provide,” said Dr. Gang. “This work includes our efforts at Magnetecs to improve the safety and efficacy of procedures for patients with arrhythmia.”
Dr. Gang obtained his Bachelor of Arts degree from Columbia College in New York City and his Masters degree from Columbia University’s College of Physicians & Surgeons. He taught Clinical Electrophysiology at Tel Hashomer Hospital in Israel and was co-Director of the Clinical Electrophysiology Laboratory at Cedars-Sinai Medical Center in Los Angeles from 1983–1988. Currently, Dr. Gang is a Clinical Professor of Medicine at the UCLA Medical School and General Partner at the Cardiovascular Medical Group of Southern California. He has authored or co-authored more than 100 manuscripts and abstracts and several book chapters, mostly in the area of clinical and experimental electrophysiology.
Dr. Gang was lead author on recently published paper entitled “Dynamically Shaped Magnetic Fields: Initial Animal Validation of a New Remote Electrophysiology Catheter Guidance and Control System” published online in advance of its appearance in the print version of the medical journal Circulation: Arrhythmia and Electrophysiology, published by the American Heart Association. The paper summarizes results of the initial feasibility study of remote electroanatomic mapping, navigation and ablation in animals, performed by the Magnetecs robotic Catheter Guidance Control and Imaging (CGCI) system. The paper can be found online here.
“We at Magnetecs are fortunate to have the talent and wisdom of Dr. Gang as Chief Medical Officer. This top US ranking is only the most recent confirmation of his qualities as a great doctor, with strong academic and peer standing. His contributions to Magnetecs and service in the highest eschelon of medicine are instrumental to the company’s growth,” said Josh Shachar, CEO of Magnetecs Corporation.
ABOUT CGCI
CGCI provides a unified system for robotic guidance, control and imaging of electrophysiology and other procedures. Previous magnetic guidance systems use large, independent magnets which emit a substantial, continuous magnetic field, have limited control capabilities, and require shielding. In contrast, Magnetecs’ CGCI system creates an electromagnetic field that is largely contained in the electromagnetic array and focused in an area no larger than the patient’s chest. CGCI emits a magnetic field only when in use and can dynamically adjust and manipulate this field to achieve unprecedented three-dimensional catheter-guidance precision, stability and responsiveness, all with safety and reliability. The CGCI system is integrated with sophisticated cardiac mapping and navigation technologies, including X-ray, intracardiac echocardiography (ICE) and other advanced electrophysiology lab technologies and equipment. Magnetecs is planning additional applications of the company’s electromagnetic technology in the fields of interventional cardiology, gastroenterology, neurology, and gynecology.
Robotic CGCI System
ABOUT MAGNETECS
Magnetecs Corporation designs and manufactures a unique and highly efficient robotic catheterization control system for minimally invasive surgical procedures and the advanced specialized tools used in these procedures. The company believes that its proprietary CGCI system will greatly improve the efficacy, safety and cost efficiency of many common minimally invasive surgeries. Magnetecs has established advanced electrophysiology surgical suites for CGCI development and testing at the company’s headquarters facility in Inglewood, California.
For Further Information, Contact:
Daniel Saks, SVP, Corporate Affairs
(310) 670-7700 |
